miR-511-3p: A Potential Therapeutic Target for Alzheimer's Disease?

Alzheimer's disease (AD) is a prevalent progressive neurodegenerative ailment that commonly affects the elderly population. An intriguing area of research in AD focuses on the abnormal expression of microRNAs observed in patients. In this study, our aim was to scrutinize the role of miR-511-3p, a microRNA closely linked to inflammation, in both AD patients and cell models simulating the disease.